Mesa Laboratories (MLAB) logo

Mesa Laboratories (MLAB) stock

Life sciences tools , market cap $750M

$127.93
-4.11%

Quality Score
10
Average
In its industry
#3of 11
Checks firing
3of 14
Choppy
From 52-week high
-11.4%
under its best in a year

MLAB's Quality Score fell 2 points on Fri, Nov 20, to 10. Its price fell under its average of 8 days (3 chart checks stopped).

See MLAB's 14 chart checksSee MLAB's 14 chart checksSee it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Why MLAB beats the market

Up 80% in a year while the S&P 500 rose 7%.

“In fiscal year 2026, revenues grew 3.4% compared to fiscal 2025, driven primarily by growth in our Sterilization and Disinfection Control division”

Its fiscal 2026 10-K said

Sources: Price history, Nov 20, 2026; Annual report (10-K), Jun 3, 2026

1 more reason, free with an account →See every reason on MLAB →4 more reasons why MLAB beats the market, from its filings, with the company's words and the timeline, for Pro members.

Key facts on MLAB

Key facts on MLAB
Since its Dec 2021 highDown 60% while sales grew 36%
Latest filing8-K, Nov 9 Reported its quarterly results

MLAB in the news

What's next

Tue Dec 1: Piper Sandler 38th Annual…Investor conference · date confirmed.

1 more date ahead: dividend dates, for Pro members.

MLAB catalysts

Coming up

After its last 4 reports it closed +2.7% on average, higher 3 of 4 times.

6 past catalysts since 2020, with sizes and sources, for Pro members.

Why MLAB scores 10

Averagefor quality, not price, 3 of 14 chart checks firingWhat the Quality Score means

  • +3Chart checks 3 of 14 firing right now, one point each
  • +3Long-term trend above a rising 200-⁠day average, near its 52-⁠week high
  • Profit addsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
  • Growth addsSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.
  • Persistence adds

No effect today: Run-up, Size, Dilution, Volatility, Cash flow, and News.

What every line is worth, and the reason behind it, on MLAB and every other stock.Get in free →See the top 3 →Start Pro

Price, score, chart checks, and the industry rank are from a snapshot taken at 8:50 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Alert me when MLAB's Quality Score turns up

A free account. No card.Pro: $1 first month.Pro, 7 days free with a card.

How MLAB ranks in Instrumentation

MLAB is #3 of 11 by Quality Score.

How MLAB ranks in Instrumentation
RankStockQuality Score
3Mesa Laboratories (MLAB) logoMLABMesa Laboratories10

More in Instrumentation

When does MLAB report earnings, and what happens after?

Expected to report Wed Feb 3, after the close (in 74 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What MLAB reported on Nov 9, 2026

The quarter

Sales of $62.3M, 3% more than a year ago; a profit of $0.75 a share, from $0.45.

“Growth was driven by SDC and CS, partially offset by BPD, which continued to be impacted by export-control processing delays, and CG.”

The quarter that ended Sep 30, from the company's press release

The press releaseThe filing on EDGAR

Where the sales came from

Where the quarter's sales came from
LineQ2
FY27
Q1
FY27
Q2
FY26
By product
Consumablesup 7.3%$35.8M57%––$33.4M55%

Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 9)

9 more lines, for Pro members.

The outlook

The outlook the company gave, by period
MeasureFigure
Fiscal 2027
Revenues$250,000 to $255,000

Figures as filed (SEC filing, Nov 9)

3 more outlook lines, for Pro members.

The numbers

Market value
$750M
today
Sales
$251M
up 2.5% on the year
Free cash flow
$49.5M
last 12 months

Sales grew 13% a year over 5 years, fiscal 2021 to 2026.

Pays $0.64 a share a year.

5 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on MLAB: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.

Close after the report, last 3

-14.5%+9.5%+7.1%
May 27Aug 10Nov 9
ReportedGapReaction5
days
Nov 9, 2026After close+1.2%+7.1%+4.9%
Aug 10, 2026After close-3.4%+9.5%+5.9%
May 27, 2026Before open-0.9%-14.5%+0.5%

MLAB closed higher after 3 of its last 4 reports.

All 4 reports, and MLAB's Quality Score going into each

MLAB sales and profit by year

Sales and profit by year

Sales grew in six of the last seven years, to $249M in 2026. It turned a profit in 2026 after a loss in 2025.

MLAB has 3 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on MLAB, and all 14 on every stock.Get in free →See the top 3 →Start Pro

MLAB RSI on Nov 20: 46.7, below its 50-day, above its 200-day

Not scored

RSI 46.7, MACD below signal, below its 50-day, above its 200-day. Not scored.

The deep dive on MLAB

11 more findings on MLAB, each with its source, for Pro members.

MLAB insider trades

One insider bought $102K across 1 filing, and 3 insiders sold $518K across 3 filings, in the last 6 months. The newest:

BuyR. Tony Tripeny$102KDirectorat $113.69 on Aug 13, filed Aug 17

All 4 insider filings on MLAB from the last six months, for Pro members.

All MLAB insider trades

MLAB's officers and directors

Officers and directors with a Form 4 in the last 12 months.

2 more officers and directors file at MLAB.

See insider trades by person

Which ETFs hold MLAB?

In ETFs: MLAB is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About Mesa Laboratories

Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.

717 employeesLakewood, COmesalabs.com

Here is what Pro members see.

  • The same page for Pro members, on Microsoft

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on MLAB and every other stock.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

  • What would move MLAB's score: 5 things
  • 3 more filings explained, a plain line each
  • Real-⁠time prices, no delay
BreakawayAug 17R. Tony Tripeny bought MLAB$102K at $113.69, filed Aug 17

Alerts are optional.

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

Straight AnswersStraight Answers

As of Nov 21, 2026: MLAB's Quality Score is 10 (Average), #3 of 11 in Instrumentation. Insiders bought $102K and sold $518K in the last 6 months (Form 4).

What does MLAB's Quality Score say?

MLAB scores 10 today, which Breakaway calls Average. It is #3 of 11 in Industrial Instruments for Measurement, Display, and Control by Quality Score, with 3 of 14 chart checks firing. Up 80% in a year while the S&P 500 rose 7%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is MLAB's Quality Score?

MLAB scores 10 today, which Breakaway calls Average (6 to 10). That is #3 of 11 in Industrial Instruments for Measurement, Display, and Control by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind MLAB's 10.

Are insiders buying MLAB?

One insider bought $102K across 1 filing, and 3 insiders sold $518K across 3 filings, in the last 6 months. The newest is R. Tony Tripeny, Director, who bought $102K on Aug 13. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Only on the public pages, which run at least 15 minutes behind. Pro members see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included. The one stock you open in full is live too.

Every US stock, ranked live.

Insider and Congress trades, the chart, and the financials, in one score.

See all 3,170 stocks rankedSee all 3,170 stocks rankedStart Pro

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.